Morgan Lewis advised Curium on the transaction. Helsinki-based law firm Krogerus served as co-counsel to Curium, advising on Finnish law.
Curium completed the acquisition of Finnish radiopharmaceuticals company MAP Medical Technologies Oy.
The acquisition of MAP Medical will further expand Curium’s footprint in Europe, providing direct access to Nordic and Baltic countries for its broad portfolio of life-saving diagnostic solutions.
Founded in 1991, MAP Medical Technologies Oy is an independent Finnish company focused on developing and manufacturing radiopharmaceuticals which improve the quality and length of human life as well as serve the needs of nuclear medicine professionals.
Curium is a nuclear medicine solutions provider with manufacturing facilities across Europe and the United States, serving patients in more than 60 countries. Curium is the largest vertically integrated radiopharmaceutical product manufacturer in the industry.
The Morgan Lewis team was led by Partner Stephen Walters (Picture), supported by Victoria Régis in Paris and Izzet Sinan in Brussels.
The Krogerus team was led by partner Mika Ståhlberg, who was assisted by senior associate Anna Metso.